This was a very important meeting with top experts that are trying to change guidelines. This FDA panel recently recommended removing the warning (“black box”) labels on menopausal HRT, citing potential benefits like reduced heart attack and bone fracture risk—and arguing the warning discourages appropriate use.
Hopefully, we will see progress in this field after the confusing and sometimes misleading conclusions of the WHI (“Women’s Health Initiative”), a large National Institutes of Health trial...
The FDA finally held a hearing on menopause—and it was long overdue. Georgie Kovacs breaks down the powerful expert testimony, the systemic failures, and why this matters for every woman navigating midlife care.
In this grounded recap, you’ll learn:
• Why the FDA’s black box warning on vaginal estrogen may be misleading
• The difference between systemic and local hormone absorption—and why it matters
• How testosterone access for women remains limited despite clear clinical need
FDA Commissioner and subject matter experts from the Center for Drug Evaluation and Research discuss the agency's recent announcement regarding removal of the “black box warning” for hormone replacement therapy.
Proposed Changes Related to Safety Information Labeling
Proposed Changes for All MHTs (Systemic and Local Vaginal Products)
Additional Proposed Changes for Systemic Products
Additional Proposed Changes for Local Vaginal Estrogen Products
The FDA just held a hearing on menopause—and experts say it’s time to rethink hormone labels. Dr. James Simon joins Fempower Health to explain what needs to change and what it means for women.
Chapters:
00:00 Intro – Why This Conversation Matters 00:14 Why Estrogen Labels Matter 00:20 Testosterone: The Missing Option for Women 06:31 Vaginal Estrogen: Creams, Rings & Pills 18:18 Breast Cancer, BRCA & Safety 26:47 Why Experts Say No New Studies Are Needed 30:07 Georgie’s Story: Vaginal...
Why are so many women still being told estrogen is dangerous?
In this episode, Dr Louise Newson is joined by oncologist and author of Estrogen Matters, Dr Avrum Bluming, to explore how fear around hormones took hold and why it persisted for so long. They also revisit the evidence behind the Women’s Health Initiative and discuss what it actually shows about risks and benefits.
Together, they unpack the role of estrogen in the body and why having the right information is key to making informed choices about treatment.
For years, many women have been told that hormones after breast cancer are simply off the table.
But what if the evidence is more nuanced than that?
In this episode, Dr. Kelly Casperson sits down with medical oncologist, researcher, and sex therapist Dr. Linda Bosserman to discuss estrogen, testosterone, breast cancer, libido, quality of life, and why individualized care matters. Together they unpack where the evidence is strong, where uncertainty remains, and why "there's no data" is not the same as "I don't know the data."
Learn more about modern approaches to menopause hormone therapy with renowned menopause and sexual medicine specialist Dr.James Simon.
In this BackTable Women’s Health discussion, Dr. James Simon and Dr. Karen Toubi explore the latest considerations in hormone therapy for perimenopause and menopause, including treatment options, risks, benefits, and individualized approaches to care.
What You’ll Learn:
* Current approaches to menopause hormone therapy
* Different types and routes of estrogen therapy
* The role of progesterone...
ExcelMale Newsletter Signup
Stay Informed with Our Newsletter
Get the latest men's health insights, expert advice, and community updates delivered to your inbox.